Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...